MedMen Enterprises, Inc. Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from Q3 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
MedMen Enterprises, Inc. quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from Q3 2019 to Q1 2023.
  • MedMen Enterprises, Inc. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending March 25, 2023 was -$36.6M, a 87.9% decline year-over-year.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$36.6M -$17.1M -87.9% Dec 25, 2022 Mar 25, 2023 10-Q 2023-07-10
Q4 2022 -$14M +$2.33M +14.2% Sep 25, 2022 Dec 24, 2022 10-Q 2023-02-02
Q3 2022 -$17.4M +$9.03M +34.1% Jun 26, 2022 Sep 24, 2022 10-Q 2023-07-10
Q1 2022 -$19.5M +$30.1M +60.7% Dec 26, 2021 Mar 26, 2022 10-Q 2023-07-10
Q4 2021 -$16.4M +$23.6M +59% Sep 26, 2021 Dec 25, 2021 10-Q 2023-02-02
Q3 2021 -$26.5M -$12.2M -84.9% Jun 27, 2021 Sep 25, 2021 10-Q 2022-11-03
Q1 2021 -$49.5M +$11.1M +18.3% Dec 27, 2020 Mar 27, 2021 10-Q 2021-05-12
Q4 2020 -$39.9M +$31.1M +43.8% Sep 28, 2020 Dec 26, 2020 10-Q 2022-02-08
Q3 2020 -$14.3M +$63.1M +81.5% Jun 25, 2020 Sep 26, 2020 10-Q 2021-11-09
Q1 2020 -$60.7M Dec 30, 2019 Mar 28, 2020 10-Q 2021-05-12
Q4 2019 -$71.1M Sep 29, 2019 Dec 28, 2019 10-Q 2021-02-16
Q3 2019 -$77.4M Jul 1, 2019 Sep 28, 2019 10-Q/A 2021-02-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.